Healthcare

  • Final Glance: Medical Devices companies Associated Press - Sat, Apr 25, 2015 10:08 AM AEST

    Shares of some top medical devices companies were mixed at the close of trading: Baxter International Inc. fell $.37 or .5 percent, to $71.14. Boston Scientific Corp. fell $.08 or .4 percent, to $18.34. ...

  • Final Glance: Pharmaceuticals companies Associated Press - Sat, Apr 25, 2015 10:08 AM AEST

    Shares of some top pharmaceuticals companies were mixed at the close of trading: Baxter International Inc. fell $.37 or .5 percent, to $71.14. Bristol-Myers Squibb Co. fell $.20 or .3 percent, to $65.80. ...

  • Final Glance: Health Care Equipment companies Associated Press - Sat, Apr 25, 2015 10:08 AM AEST

    Shares of some top health care equipment companies were mixed at the close of trading: Becton, Dickinson & Co. fell $.02 or percent, to $144.33. Patterson rose $.70 or 1.5 percent, to $48.19. PerkinElmer ...

  • Final Glance: Drugstore companies Associated Press - Sat, Apr 25, 2015 10:08 AM AEST

    Shares of some top drugstore companies were mixed at the close of trading: CVS Health Corp. rose $.70 or .7 percent, to $101.58. Rite Aid fell $.01 or .1 percent, to $8.25. Walgreen Boots Alliance Inc. ...

  • Final Glance: Drug Benefits companies Associated Press - Sat, Apr 25, 2015 10:08 AM AEST

    Shares of some top drug benefits companies were up at the close of trading: CVS Health Corp. rose $.70 or .7 percent, to $101.58. Express Scripts Holding Co. rose $.45 or .5 percent, to $87.34.

  • Final Glance: Biotechnology companies Associated Press - Sat, Apr 25, 2015 10:08 AM AEST

    Shares of some top biotechnology companies were mixed at the close of trading: Amgen Inc. fell $1.26 or .7 percent, to $167.91. Biogen Idec fell $28.57 or 6.6 percent, to $401.71. Celgene Corp. rose $2.62 ...

  • Mylan makes official bid for Perrigo in generic drug contest Associated Press - Sat, Apr 25, 2015 7:03 AM AEST

    Generic drugmaker Mylan is making official its offer for over-the-counter medicines maker Perrigo as it remains at the center of a three-way battle: Mylan wants to buy Perrigo, while a larger rival wants ...

  • Insurance department explores health care payment reform Associated Press - Sat, Apr 25, 2015 4:05 AM AEST

    Health care spending is high and rising in New Hampshire, and the state should consider holding both providers and insurers accountable for improving quality and containing costs, consultants hired by ...

  • Midday Glance: Pharmaceuticals companies Associated Press - Sat, Apr 25, 2015 3:36 AM AEST

    Shares of some top pharmaceuticals companies are mixed at 1 p.m.: Baxter International Inc. fell $.39 or .5 percent, to $71.12. Bristol-Myers Squibb Co. fell $.28 or .4 percent, to $65.72. Eli Lilly & ...

  • Midday Glance: Medical Devices companies Associated Press - Sat, Apr 25, 2015 3:36 AM AEST

    Shares of some top medical devices companies are mixed at 1 p.m.: Baxter International Inc. fell $.39 or .5 percent, to $71.12. Boston Scientific Corp. fell $.07 or .4 percent, to $18.35. Johnson & Johnson ...

  • Midday Glance: Health Care Equipment companies Associated Press - Sat, Apr 25, 2015 3:36 AM AEST

    Shares of some top health care equipment companies are mixed at 1 p.m.: Becton, Dickinson & Co. fell $.01 or percent, to $144.34. Patterson rose $.81 or 1.7 percent, to $48.30. PerkinElmer rose $.13 or ...

  • Midday Glance: Drugstore companies Associated Press - Sat, Apr 25, 2015 3:36 AM AEST

    Shares of some top drugstore companies are mixed at 1 p.m.: CVS Health Corp. rose $.79 or .8 percent, to $101.67. Rite Aid rose $.01 or .1 percent, to $8.27. Walgreen Boots Alliance Inc. fell $.40 or .5 ...

  • Midday Glance: Drug Benefits companies Associated Press - Sat, Apr 25, 2015 3:36 AM AEST

    Shares of some top drug benefits companies are up at 1 p.m.: CVS Health Corp. rose $.79 or .8 percent, to $101.67. Express Scripts Holding Co. rose $.18 or .2 percent, to $87.07.

  • Midday Glance: Biotechnology companies Associated Press - Sat, Apr 25, 2015 3:36 AM AEST

    Shares of some top biotechnology companies are mixed at 1 p.m.: Amgen Inc. fell $1.01 or .6 percent, to $168.16. Biogen Idec fell $25.40 or 5.9 percent, to $404.88. Celgene Corp. rose $3.05 or 2.6 percent, ...

  • Perrigo rejects formal Mylan takeover offer Financial Times - Sat, Apr 25, 2015 2:46 AM AEST

    Perrigo on Friday rejected a formal takeover offer from its bigger generic drugs rival Mylan, escalating a three-way takeover battle as Mylan attempts to fend off an unsolicited approach from Israel's ...

  • Early Glance: Pharmaceuticals companies Associated Press - Sat, Apr 25, 2015 12:55 AM AEST

    Shares of some top pharmaceuticals companies are mixed at 10 a.m.: Baxter International Inc. fell $.42 or .6 percent, to $71.09. Bristol-Myers Squibb Co. fell $.11 or .2 percent, to $65.89. Eli Lilly & ...

  • Early Glance: Health Care Equipment companies Associated Press - Sat, Apr 25, 2015 12:55 AM AEST

    Shares of some top health care equipment companies are mixed at 10 a.m.: Becton, Dickinson & Co. rose $.50 or .3 percent, to $144.85. Patterson rose $.14 or .3 percent, to $47.64. PerkinElmer fell $.05 ...

  • Early Glance: Managed Care companies Associated Press - Sat, Apr 25, 2015 12:55 AM AEST

    Shares of some top managed care companies are mixed at 10 a.m.: Aetna fell $.46 or .4 percent, to $108.44. Anthem fell $.21 or .1 percent, to $153.99. Cigna Corp. fell $.09 or .1 percent, to $130.48. Humana ...

  • AstraZeneca forced to defend cancer drug deal with Celgene Financial Times - Sat, Apr 25, 2015 12:43 AM AEST

    AstraZeneca will receive a $450m windfall from Celgene as part of a partnership to develop cancer drugs together - but the UK drugmaker was forced to defend the deal against claims it was trading future ...

  • Here's what Obamacare customers think... CNBC - Fri, Apr 24, 2015 11:00 PM AEST
    Here's what Obamacare customers think...

    A new study shows that Obamacare customers are more satisfied with their plans than people with job-based insurance.

  • Biogen misses Street 1Q forecasts Associated Press - Fri, Apr 24, 2015 9:22 PM AEST

    On a per-share basis, the Cambridge, Massachusetts-based company said it had profit of $3.49. Earnings, adjusted for one-time gains and costs, were $3.82 per share. The results missed Wall Street expectations. ...

  • AstraZeneca profit falls as patent expires on heartburn drug Associated Press - Fri, Apr 24, 2015 6:56 PM AEST

    Anglo-Swedish drug-maker AstraZeneca PLC reported a 7 percent fall in net profit for the first quarter of 2015, as cheaper copies of one of its best-sellers ate into sales. Net profit for the three months ...

  • Big pharma mergers: Mylan boosts offer for Perrigo AFP - Fri, Apr 24, 2015 6:11 PM AEST
    Big pharma mergers: Mylan boosts offer for Perrigo

    Generic drug company Mylan increased its offer for over-the-counter giant Perrigo Friday, days after Israel's Teva attempted to head off that deal with its own bid for Mylan. Complaining that the company's board has refused to enter talks, Mylan made a formal offer to Perrigo shareholders of $60 plus 2.2 Mylan shares for each Perrigo share. The bid was worth about $222 dollars per share, or around $32.6 billion in total, based on Mylan's closing price on Thursday.

  • ResMed beats 3Q profit forecasts Associated Press - Fri, Apr 24, 2015 8:10 AM AEST

    The San Diego-based company said it had net income of 64 cents per share. Earnings, adjusted for amortization costs, came to 65 cents per share. The results topped Wall Street expectations. The average ...

  • Encore Wire posts 1Q profit Associated Press - Fri, Apr 24, 2015 7:09 AM AEST

    The McKinney, Texas-based company said it had net income of 52 cents per share. The copper wire maker posted revenue of $250.3 million in the period. Encore Wire shares have climbed 11 percent since the ...

  • Merit Medical posts 1Q profit Associated Press - Fri, Apr 24, 2015 6:51 AM AEST

    On a per-share basis, the South Jordan, Utah-based company said it had net income of 12 cents. Earnings, adjusted for one-time gains and costs, came to 18 cents per share. The maker of disposable medical ...

  • Johnson & Johnson hikes quarterly dividend 7 percent Associated Press - Fri, Apr 24, 2015 5:06 AM AEST

    Johnson & Johnson on Thursday said it's raising its quarterly dividend by 7 percent, marking its 53rd straight year of dividend increases. The world's biggest maker of health care products announced the ...

  • AbbVie raises outlook as Humira again delivers earnings beat Associated Press - Fri, Apr 24, 2015 12:48 AM AEST
    AbbVie raises outlook as Humira again delivers earnings beat

    Drugmaker AbbVie is raising its full-year earnings guidance after reporting better-than-expected first quarter adjusted results on continued growth of its blockbuster anti-inflammatory drug Humira. However, ...

  • AbbVie raises guidance after 1Q sales beat Associated Press - Thu, Apr 23, 2015 11:47 PM AEST
    AbbVie raises guidance after 1Q sales beat

    Drugmaker AbbVie is raising its full-year earnings guidance after reporting better-than-expected first quarter adjusted results on continued growth of its blockbuster anti-inflammatory drug Humira. However, ...

  • Utah Medical posts 1Q profit Associated Press - Thu, Apr 23, 2015 11:18 PM AEST

    The Midvale, Utah-based company said it had net income of 71 cents per share. The medical device maker posted revenue of $10.2 million in the period. Utah Medical shares have declined almost 7 percent ...

  • Novartis starts to reap rewards of revamp Financial Times - Thu, Apr 23, 2015 5:57 PM AEST

    Novartis announced better-than-expected first quarter profits on Thursday as it began to show the benefits of a sweeping overhaul that has left the Swiss healthcare group more streamlined and focused. ...

  • Divestment gains boost net earnings at drug company Novartis Associated Press - Thu, Apr 23, 2015 4:58 PM AEST

    Swiss-based pharmaceutical company Novartis reported a large jump in first-quarter net profit Thursday as it recorded one-time gains from deals with other drug companies. Net profit rose to $13.005 billion ...

  • Novartis keeps full-year target as Q1 earnings fall AFP - Thu, Apr 23, 2015 11:49 AM AEST
    Novartis keeps full-year target as Q1 earnings fall

    Swiss pharmaceutical giant Novartis on Thursday said its first quarter income had fallen but maintained it would still meet its targets for this year. Novartis, which formed a joint venture with Britain's GlaxoSmithKline for consumer health products and sold an animal health division to Eli Lilly, said net profits rose to $13 billion if those transactions were included. We have completed the GSK and Lilly transactions and innovation continues to be strong," Novartis chief Joseph Jimenez said.

  • Roche sales up 3 percent amid demand for breast cancer drugs Associated Press - Thu, Apr 23, 2015 12:02 AM AEST

    Breast cancer drugs such as Herceptin as well as new uses for multi-cancer drug Avastin helped Swiss pharmaceutical firm Roche grow sales by 3 percent during the first quarter. Group sales rose 3 percent ...

  • Amgen tops estimates, grows profit 51% AAP - Wed, Apr 22, 2015 8:30 PM AEST
    Amgen tops estimates, grows profit 51%

    Amgen Inc has boosted its first-quarter profit by 51 per cent, thanks to surging drug sales and ongoing cost cuts designed to free up cash for an unprecedented burst of new product launches. Repatha is part of a new class of pricey cholesterol drugs called PCSK9 inhibitors aimed at patients not helped enough by older statin drugs such as Lipitor. Amgen reported net income of $US1.62 billion ($A2.10 billion), or $US2.11 per share, up from $US1.07 billion, or $US1.40 per share, in 2014's first quarter. "It was a solid quarter," said Edward Jones analyst Ashtyn Evans.